Lucira Health, Inc. Form 8-K (June 1, 2022)

Summary

Current report on Form 8-K of Lucira Health, Inc. dated June 1, 2022, reporting under Item 5.07, Submission of Matters to a Vote of Security Holders. The company states that the annual meeting of stockholders took place on June 1, 2022. Stockholders elected David Lamond (17,975,889 votes for, 916,277 withheld), Alison McCauley (18,166,531 for, 725,635 withheld) and Tuff Yen (18,631,564 for, 260,602 withheld) as Class I directors, with 7,698,574 broker non-votes each. Stockholders ratified BDO USA, LLP as independent registered public accounting firm for the fiscal year ending December 31, 2022, with 26,468,740 votes for, 63,152 against and 58,848 abstaining. The signature block is Daniel George, Chief Financial Officer.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 01, 2022

Lucira Health, Inc.

(Exact name of Registrant as Specified in Its Charter)

Delaware | 001-39976 | 27-2491037
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.)
1412 62nd Street
Emeryville , California | 94608
(Address of Principal Executive Offices) | (Zip Code)
Registrant’s Telephone Number, Including Area Code: 510 350-8071

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol(s) | Name of each exchange on which registered
Common Stock, par value $0.001 per share | LHDX | NASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 1, 2022, Lucira Health, Inc. (the “Company”) held its 2022 Annual Meeting of Stockholders (the “2022 Annual Meeting”). At the 2022 Annual Meeting, the Company’s stockholders voted on the following proposals and cast their votes as set forth below. A more detailed description of each proposal is set forth in the Company’s Proxy Statement filed with the Securities and Exchange Commission on April 20, 2022.

Proposal 1. Election of Directors

The Company’s stockholders elected the individuals listed below as Class I Directors, to serve until the Company’s 2025 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified or until his or her earlier resignation or removal. The final voting results are as follows:

For | Against | Withheld | Broker Non-Votes
David Lamond | 17,975,889 | — | 916,277 | 7,698,574
Alison McCauley | 18,166,531 | — | 725,635 | 7,698,574
Tuff Yen | 18,631,564 | — | 260,602 | 7,698,574

Proposal 2. Ratification of the Selection of Independent Registered Public Accounting Firm

The Company’s stockholders ratified the selection of BDO USA, LLP by the Audit Committee of the Company’s Board of Directors as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022. The final voting results are as follows:

For | Against | Abstain | Broker Non-Votes
26,468,740 | 63,152 | 58,848 | —

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Lucira Health, Inc.
Date: | June 2, 2022 | By: | /s/ Daniel George
Daniel George Chief Financial Officer

File and source

File

SEC_LHDX_8-K_filed2022-06-02_0000950170-22-011094.htm

Size

77,356 bytes

SHA-256

e34eb314cb5fabee2101953bc9c5e9bc5affd98f4a36b52115fc874b7f2ccc85

Our copy

SEC_LHDX_8-K_filed2022-06-02_0000950170-22-011094.htm

Original

www.sec.gov